Transforming Growth Factor beta 1 (TGFb1, TGF-beta-1, TGFB1, TGFB) (HRP)

Cat# T8250-16E-HRP-100ul

Size : 100ul

Brand : US Biological

Contact local distributor :


Phone : +1 850 650 7790


T8250-16E-HRPTransforming Growth Factor beta 1 (TGFb1, TGF-beta-1, TGFB1, TGFB) (HRP)

Specifications
Clone TypeMonoclonal
Hostmouse
Sourcehuman
Swiss ProtP01137
IsotypeIgG1
GradeAffinity Purified
ApplicationsE IHC WB
CrossreactivityHu Mo Rb Rt Sh
Shipping TempBlue Ice
Storage Temp-20°C

TGFb1 (Transforming Growth Factor-beta1) is a family of multifunctional 25kD proteins. TGFb1 was originally identified for its ability to induce the growth of normal rodent fibroblasts in soft agar. It is now known that TGFb1 is a potent growth inhibitor of many normal and transformed cell lines. It regulates normal cell growth, development and tissue remodeling following injury. TGFb1 is produced as latent high molecular weight complexes. The activation of latent TGFb1 is an important step in the regulation of its action.

Applications:
Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications have not been tested.

Recommended Dilutions:
Immunohistochemistry: Frozen sections
Immunohistochemistry (Paraffin): Has been successfully used on FFPE tissue without pre-treatment. Can use citrate, pH 6, EDTA, pH 8, or pepsin mediated antigen retrival.
Optimal dilutions to be determined by the researcher.

Recommended Negative Control:
I1904-78R: IgG1 Murine Negative Control

IHC Postivie Control:
Human Breat Carcinoma

Hybridoma:
SP2/0-Ag 14 myeloma cells with spleen cells from Balb/c mice.

Storage and Stability:
Store product at 4°C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C. Aliquots are stable at -20°C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Note: Applications are based on unconjugated antibody.

Applications
Product Type: Mab|Isotype: IgG1|Clone No: 10F521 (TB21)|Host: mouse|Source: human|Concentration: As Reported|Form: Supplied as a liquid in PBS, pH 7.2. Labeled with horseradish peroxidase (HRP).|Purity: Purified by affinity chromatography.|Immunogen: Human Transforming Growth Factor beta 1 from platelets.|Specificity: Recognizes human platelet-derived and recombinant Transforming Growth Factor beta 1 in ELISA. Demonstrates neutralizing activity against TGF-beta1 in cell proliferation assays. Demonstrated to react with dimeric (25kD) or monomeric (12.5kD) molecules of natural TGFb1 under non-reducing and reducing conditions respectively. Species Crossreactivity: rat, sheep, mustelid, rabbit, mouse, mink||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Human Transforming Growth Factor beta 1 from platelets.
Form
Supplied as a liquid in PBS, pH 7.2. Labeled with horseradish peroxidase (HRP).
Purity
Purified by affinity chromatography.
Specificity
Recognizes human platelet-derived and recombinant Transforming Growth Factor beta 1 in ELISA. Demonstrates neutralizing activity against TGF-beta1 in cell proliferation assays. Demonstrated to react with dimeric (25kD) or monomeric (12.5kD) molecules of natural TGFb1 under non-reducing and reducing conditions respectively. Species Crossreactivity: rat, sheep, mustelid, rabbit, mouse, mink
References
1. Lehr, E.J.et al. (2010) Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J Thorac Cardiovasc Surg. Jul 14. [Epub ahead of print] 2. Westermann, D. et al. (2011) Circ Heart Fail. 4: 44­52. 3. Brown, H. et al. (1999) J Infect Dis. 180: 1742­6. 4. Helske, S. et al. (2006) Eur Heart J. 27: 1495­504. 5. Hsiao, Y.W. et al. (2004) J Immunol. 172: 1508­14. 6. Kingston, P.A. et al. (2003) Circulation. 108: 2819­25. 7. Lavaud, S. et al. (2001) Am J Physiol Renal Physiol. 280: F683­94. 8. Sheu, B.C. et al. (2001) J Immunol. 167: 2972­8. 9. Hopkinson, A. et al. (2006) Invest Ophthalmol Vis Sci. 47: 4316­22. 10. Sumpter, T.L. et al. (2007) J Leukoc Biol. 83: 708­17. 11. Braun, N. et al. (2011) Perit Dial Int. 31: 291­ 300. 12. Shi, W.K. et al. (1993) [Biological characterization of a monoclonal antibody TB 21 against human transforming growth factor­beta 1]. Shi Yan Sheng Wu Xue Bao. 26: 141­50.